Unit
Genome Integrity, RNA and Cancer (UMR3348)
Thematic areas of research:
Image
![Image couverture UMR3348](/sites/default/files/styles/header_sciences/public/medias/images/2021-05/BANDEAU-UMR3348-6.jpg?h=3135cca3&itok=jLtGol_L)
To top
Unit
STEPHAN VAGNER / SARAH LAMBERT
Genome Integrity, RNA and Cancer (UMR3348)
The research conducted at the « Genome Integrity, RNA and Cancer » Unit explores multiple aspects of genome dynamics that integrate RNA biology in the context of genome maintenance and expression in normal and pathological situations, including cancer.
Teams
Key figures
25
km from Paris
25
nationalities since 2015
25
INTERNATIONAL EVENTS ORGANISED
Key publications
All publications
-
-
-
The plasticity of mRNA translation during cancer progression and therapy resistanceNature Reviews Cancer
-
-
-
-
-
Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1Nature Communications
-
-
-
Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against CancerClinical Cancer Research
-
-
News
All news
-
New results for better treatment of T-cell acute lymphoblastic leukemiaT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive type of blood cancer characterized by the proliferation of T-lymphocyte precursors that are abnormally arrested in their differentiation. A new Institut Curie study led by Drs. Christine Tran Quang and Jacques Ghysdael, researchers in the RNA Biology, Signalling and Cancer team of the Genome Integrity, RNA and Cancer unit (CNRS UMR 3348 / Université Paris-Saclay), characterizes the anti-leukemic effects of an immunotherapy targeting the T-cell antigen receptor. These results, published in Blood on May 23, 2024, pave the way for the development of new therapies.15/07/2024
-
World Triple Negative Breast Cancer Day: innovation to cure more womenWorld Triple Negative Breast Cancer Day, held on March 3rd, is a reminder that triple-negative breast cancers remain the most difficult to treat, and that only innovation and dynamic research can bring hope of curing more patients.01/03/2024
-
Dr. Albertas Navickas, winner of the prix Ruban Rose Avenir 2023Dr. Albertas Navickas, head of the RNA, Tumor Microenvironment and Metastasis team in the Genome integrity, RNA and Cancer unit (CNRS UMR3348/University Paris-Saclay), was recognized by the Ruban Rose association for his promising project on communication between cancer cells of the breast and the cells of the lungs.24/10/2023
-
New major players in the protection of DNA replication forks are identifiedIn an article published on March 2, 2023, in the journal Molecular Cell, the team led by Sarah Lambert, in collaboration with researchers from the Institute for Integrative Biology of the Cell, revealed a mechanism that ensures the integrity of DNA replication forks. Based on the combination of RNA and the end-joining factor Ku, it represents a potential new therapeutic target to fight cancerous cells.13/03/2023
-
Three research projects at Institut Curie financed by the ERC Synergy GrantThree projects at Institut Curie are laureate of the highly selective and prestigious Synergy Grant 2022 program, awarded by the European Research Council. These three grants, for an amount of 10 million euros each, shine a light on Institut Curie’s excellence and its teams in cellular biology. A breakthrough field to further the fight against cancer.28/10/2022
-
Carsten Janke awarded an ERC Advanced GrantLong-neglected, research on post-translational modifications of microtubules is now a promising field, thanks in particular to Carsten Janke, a world expert in this area. His excellence in this discipline and the hopes placed in his research have been recognized by the European Research Council (ERC).12/08/2022
Scientific events
All scientific events
10 Jun
2024
Seminar
14h-23h
Cracking the 9+2 Code of Motile Cilia
The axoneme of motile cilia is the largest macromolecular machine of eukaryotic cells. In humans, impaired axoneme function causes a range of ciliopathies. In most motile cilia, the axoneme has a 9+2 architecture in which nine doublet microtubules surround a central pair of singlet microtubules. Use single-particle cryo-EM, we could visualize and build atomic models of the native repeating structu
26 Apr
2024
Seminar
11h-12h
On the multiple roads to cell fate decisions: Integrating transcription factors into RNA-regulatory networks
While the current view states that Transcription Factors (TFs) act on DNA regulatory elements to deploy precise gene programs, an emerging concept proposes that TFs also bind RNA and regulate splicing to promote molecular and cellular diversity. Yet, how the RNA regulatory functions of TFs contribute to their key role in cell fates remains puzzling. From in vitro interaction to tissue development,
3 Apr
2024
Seminar
11h-23h
Vimentin intermediate filaments: network architecture and crosstalk with microtubules
The spatial organization and dynamics of the cytoskeleton play crucial roles for various cellular functions. However, despite their essential roles in processes such as cell migration, mechanical stress resilience, and maintaining cellular integrity, the complex nature of vimentin intermediate filament networks continues to elude our understanding. Unlike actin and microtubules, recreating physiol
21 Mar
2024
Institutional seminar "Mayent - Rothschild"
11h-12h
A garden of forking paths: branching, switching and reversal in meiotic recombination
Meiotic recombination involves repair of double strand DNA breaks by homologous recombination to form crossovers and noncrossovers. Current models suggest that different mechanisms form these two products: noncrossovers by synthesis dependent strand annealing; COs by double Holliday junction formation and resolution. In testing these predictions, we found evidence for remarkable dynamism during me
15 Dec
2023
Seminar
11h-12h
The dangerous combination of DNA structures and chromosome gaps: implications for repeat instability and cell survival
The Freudenreich lab uses the yeast Saccharomyces cerevisiae (baker's yeast) as a model organism to study genome instability. In particular, we investigate the molecular basis of two related types of DNA mutations: repeat expansions and chromosome fragility. Expansion of repeat sequences is the cause of more than 20 inherited diseases including Huntington's disease, Fragil
Job offers
All job offers
-
Post-doctorat en biologie de l’ARN (H/F)L'Institut Curie est un acteur majeur de la recherche et de la lutte contre le cancer. Il est constitué d'un hôpital et d'un Centre de recherche de plus de 1000 collaborateurs avec une forte représentativité internationale.L’objectif du Centre de recherche de l’institut Curie est de développer la recherche fondamentale et d’utiliser les connaissances produites pour améliorer le diagnostic, le pronostic, la thérapeutique des cancers dans le cadre du continuum entre la recherche fondamentale et l’innovation au service du malade.
-
Postdoctoral -Molecular & Cellular Genetics (M/F)The Institut Curie is a major player in the research and fight against cancer. It consists of a hospital and a Research Center of more than 1000 employees with a strong international representativeness. The objective of the Curie Institute Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis, prognosis, and therapeutics of cancers as part of the continuum between basic research and innovation serving the patient.